TETERBORO, N.J., March 29 /PRNewswire/ -- Quest Diagnostics Incorporated
(NYSE: DGX), the nation's leading provider of diagnostic testing, information
and services, announced that it is scheduled to make presentations at two
investor conferences during the next week.
Kenneth W. Freeman, Chairman and Chief Executive Officer, is scheduled to
speak at the Banc of America Securities Healthcare Conference on Thursday,
March 29, 2001 at the Four Seasons Hotel in Las Vegas, Nevada. The Quest
Diagnostics presentation is scheduled to begin at approximately 1:30 p.m.
Eastern Time. The public is invited to listen to a live webcast of the
presentation on the Internet by visiting the following web address:
http://www.veracast.com/bas_healthcare2001/webcasts/id81305402.cfm. A replay
of the webcast will be available for two weeks following the conference.
In addition, Robert A. Hagemann, Corporate Vice President and Chief
Financial Officer, is scheduled to make a presentation at the Thomas Weisel
Partners Healthcare Tailwinds 2001 Conference on Tuesday, April 3, 2001, at
the Ritz Carlton Hotel in San Francisco, California. The Quest Diagnostics
presentation is scheduled to begin at approximately 6:20 p.m. Eastern Time.
The public is invited to listen to a live webcast of the presentation on the
Internet by visiting the following web address:
http://www.veracast.com/twp_healthcare_2001/webcasts/44211125.cfm. A replay of
the webcast will be available for 30 days following the conference.
Quest Diagnostics will release financial results for the first quarter
ending March 31, 2001, after the close of the stock market on April 23, 2001.
The company is currently in a "quiet" period and will discuss results for the
first quarter during a conference call on April 24 at 8:00 a.m. Eastern Time.
To hear a simulcast of the call over the Internet, or a replay, registered
analysts may access StreetEvents at: http://www.streetevents.com and all
others may access the Quest Diagnostics website at:
http://www.questdiagnostics.com. In addition, a replay of the call will also
be available from 10 a.m. on April 24 through 5 p.m. on April 26 to investors
in the U.S. by dialing 800-342-8825. Investors outside the U.S. may dial
402-220-9674. No password is required for either number.
Quest Diagnostics is the nation's leading provider of diagnostic testing,
information and services with $3.4 billion in annual revenues. The company's
diagnostic testing yields information that enables health care professionals
and consumers to make better decisions to improve health. Quest Diagnostics
offers patients and physicians the broadest access to diagnostic testing
services through its national network of approximately 30 full-service
laboratories, 150 rapid response laboratories and more than 1,300 patient
service centers, where specimens are collected. Quest Diagnostics is the
leading provider of esoteric testing, including gene-based testing, and is the
leader in routine medical testing, drugs of abuse testing, and anatomic
pathology testing. Through partnerships with pharmaceutical, biotechnology
and information technology companies, Quest Diagnostics provides support to
help speed the development of health care insights and new therapeutics.
Additional company information can be found on the Internet at:
http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause the outcome to be
materially different. Certain of these risks and uncertainties are listed in
the Quest Diagnostics Incorporated 1999 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
CONTACT: Media - Mary Samuels, 201-393-5700, or Investors - Cathy
Doherty, 201-393-5030, both for Quest Diagnostics Incorporated/